1. Clinical impact of selective transarterial choembolization on hepatocellular carcinoma: A cohort study

Rodolfo Sacco, Marco Bertini, Pasquale Petruzzi, Michele Bertoni, Irene Bargellini, Giampaolo Bresci, Graziana Federici, Luigi Gambardedella, Salvatore Metrangolo, Giuseppe Parisi, Antonio Romano, Antonio Scaramuzzino, Emanuele Tumino, Alessandro Silvestri, Emanuele Altomare, Claudio Vignali, Alfonso Capria World Journal of Gastroenterology 2009 April 14; 15 (14): 0000-0000

 

2. Selective transcatheter arterial chemioembolization for hepatocellular carcinoma: evaluation of clinical impact-short and long/term prospective study

Rodolfo Sacco, Marco Bertini, Pasquale Petruzzi, Michele Bertonii, Giampaolo Bresci, Graziana Federici, Luigi Gambardedella, Salvatore Metrangolo, Giuseppe Parisi, Antonio Romano, Antonio Scaramuzzino, Emanuele Tumino, Emanuele Altomare, Claudio Vignali, Alfonso Capria

Digestive and Liver Disease Volume 41 Iusse 5 May 2009 A1-A19

 

3. Conventional transcatheter arterial chemoembolization ( C-TACE ) versus doxorubicin eluting bead ( DEB )-TACE for hepatocellular carcinoma: assessment of clinical impact- short and long-term prospective study

R. Sacco, M. Bertini, I. Bargellini, P. Petruzzi, G. Federici, E. Bozzi, M. Bertoni, B. Ginanni, G. Bresci, A. Romano, R. Cioni, e. Altomare,, C. Bartolozzi, A. Capria

Journal of Hepatology Supplement N.1 Vol. 52 2010

 

4. Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease

Rodolfo Sacco, Marco Bertini, Giampaolo Bresci, Antonio Romano, Emanuele Altomare, Alfonso Capria

Hepato-Gastroenterology 2010; 57: 285-289

 

5. Conventional vs doxorubicin eluting bead transcatheter arterial chemoembolization for hepatocellular carcinoma

R. Sacco, M. Bertini, A. Romano, E. Bozzi, G. Federici, B. Ginanni, G. Bresci, P. Petruzzi, E. Tumino, R. Cioni, S. Cetrangolo, E. Altomare, A. Capria, C. Bartolozzi

EASL – Special conference Hepatocellular Carcinoma: from Genomics to Treatment Dubrovnik, Croatia June 25-26 , 2010 p. 138

 

6. Conventional vs doxorubicin eluting bead transcatheter arterial chemoembolization for hepatocellular carcinoma

R. Sacco, I. Bargellini, M. Bestini, E. Bozzi, E. Tumino, B. Ginanni, A. Romano, R. Cioni, G. Bresci, P. Petruzzi, S. Metrangolo, A. Cicorelli, G. Parisi, M. Bertoni, E. Altomare, A. Capria, C. Bartolozzi

Gut, november 2010 Vol. 59 Supplement III A246

 

7. SURVIVAL AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN EARLY-STAGE HCC

PATINTS EXCLUDED FROM LIVER TRASPLANTION: A PROSPECTIVE COHORT STUDY
R. Sacco, I. Bargellini, M. Bertini, E. Bozzi, E. Tumino, B. Ginanni, A. Romano, G. Bresci, R. Cioni,

G. Federici, E. Altomare, A. Capria, C. Bartolozzi Gut, november 2010 Vol. 59 Supplement III A246

 

8. Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective cohort study

G. Bresci, A. Romano, A. Mazzoni, F. Scatena, E. Altomare, A. Capria, R. Sacco Gastroenterologie Clinique et Biologique – ELSEVIER MASSON – ( 2010 ) 34, 682-686

 

9. Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective cohort study

R. Sacco, A. Romano , A. Mazzoni , M. Bertini , M. Bretoni, F. Scatena , G. Federici, S. Metrangolo , G. Parisi, E. Tumino, A. Scaramuzzino, E. Altomare, A. Capria, G. Bresci

Journal of Crohn’s & Colitis – Volume 5 Iusse 1, February 2011

 

10. Complete response for advanced liver cancer during sorafenib therapy: Case Report

Rodolfo Sacco, Irene Bargellini, Giannelli Gianluigi, marco bertini, Elena Bozzi, Emanuele Altomare, Valentina Battaglia, Antonio Romano , MIchele Bertoni , Alfonso Capria , Giampaolo Bresci , Carlo Bartolozzi

BMC Gastroenterology 2011, 11:4

 

11. GRANULOCYTEAPHERESIS ( GCAP ) IN INFLAMMATORY BOWEL DISEASE. A

PROSPECTIVE, SINGLE CENTER EXPERIENCE

R. Sacco , A. Romano, M. Bertini, A. Mazzoni, G. Federici, M. Bertoni, A. Scaramuzzino , G. Parisi , S. Metrangolo , E. Tumino , F. Scatena , E. Altomare , G, Bresci

Digestive and Liver Disease Volume 43 Supplement 3 March 2011 ISSN 1590-8658

 

12. ENDOTICS SYSTEM VS COLONSCOPY FOR THE DETECTION OF POLYPS
E. Tumino , M. Bertini, M. Bertoni, G. Parisi , G. Bresci , A. Capria , A. Romano , R. Sacco

Digestive and Liver Sisease Volume 43 Supplement 3 March 2011 ISSN 1590-8658

 

13. LONG-TERM RESULTS OF SORAFENIB IN ADVANCED-STAGE HEPATOCELLULAR : WHAT CAN WE LEARN FROM DAILY CLINICAL PRACTICE

R. Sacco, I. Bargellini, B. Ginanni, M. Bertini, A. Romano , G. Federici , G. Parisi , E. Bozzi , M. Bertoni , A. Scaramuzzino , S. Metrangolo , E. Tumino , E. Altomare , A. Capria , G. Bresci , C. Bartolozzi

Digestive and Liver Disease Volume 43 Supplement 3 March 2011 ISSN 1590-8658

 

14. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.

Sacco R, Bargellini I, Bertini M, Bozzi E, Romano A, Petruzzi P, Tumino E, Ginanni B, Federici G, Cioni R, Metrangolo S, Bertoni M, Bresci G, Parisi G, Altomare E, Capria A, Bartolozzi C.

J Vasc Interv Radiol. 2011 Nov;22(11):1545-52

 

15. Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient.

Sacco R, Bargellini I, Ginanni B, Bertini M, Bozzi E, Altomare E, Battaglia V, Romano A, Tumino E, Di Biase M, Bresci G, Bartolozzi C.

J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S89-92

 

16 . EARLY OF RESPONSE TO SORAFENIB IN ADAVANCED HEPATOCELLULAR CARCINOMA USING PERFUSIONAL COMPUTED TOMOGRAPHY:PILOT STUDY

R.Sacco, L.Bargellini, B.Ginanni, A. Romano, L.Faggiani, M.Bertoni, G.Federici, S.Metrangolo, G.Parisi, a. Scaramuzzino, E. Tumino, G. Bresci, C. Bartolozzi

Digestive and Liver disease 44S (2012) S55-S220

 

17. Early of response to sorafenib in adavaced hepatocellular carcinoma using

perfusional computed tomography:pilot study

R. Sacco, I. Bargellini, B. Ginanni, M. Bertini, A. Romano, L. Faggioni, M. Bertoni, G. Federici, S. Metrangolo, G. Parisi, E. Tumino, A. Scaramuzzino, G. Bresci, C. Bartolozzi

Digestive and Liver Disease 44S (2012), S1-S48

 

18. EARLY ASSESSMENT OF RESPONSE TO SORAFENIB IN ADVANCED HEPATOCELLULAR CARCINOMA USING PERFUSIONAL COMPUTED TOMOGRAPHY: PILOT STUDY

R.Sacco, L.Faggioni, A. Romano, I. Bargellini, M.Bertini, B. Ginanni, M. Bertoni, G. Federici, V. Battaglia, S. Metrangolo, G. Parisi, A. Scaramuzzino, e. Tumino, G. Bresci, C. Bartolozzi

Journal of Hepatology 2012 vol 56 S389-S548

 

19. Ramp-up strategy and long-term results of sorafenib in advanced-stage hepatocellular carcinoma under daily clinical practice conditions

R.Sacco, L.Bargellini, B.Ginanni,M.Bertini, A. Romano, M.Bertoni, G.Federici, S.Metrangolo, G.Parisi, E. Tumino A. Scaramuzzino, G. Bresci, C. Bartolozzi

Digestive and Liver disease 44S (2012) S1-S48

 

20. THERAPEUTIC EFFICACY OF GRANULOCYTAPHERESIS IN INFLAMMATORY BOWEL DISEASES: A PROSPECTIVE OBSERVATIONAL STUDY

R.Sacco, A. Romano, M.Bertini, G.Federici, S.Metrangolo, G.Parisi, A. Scaramuzzino, M.Bertoni, A.Mazzoni, E.Tumino, F.Scatena,G. Bresci

Digestive and Liver disease 44S (2012) S55-S220

 

21. Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

Bargellini I, Sacco R, Bozzi E, Bertini M, Ginanni B, Romano A, Cicorelli A, Tumino E, Federici G, Cioni R, Metrangolo S, Bertoni M, Bresci G, Parisi G, Altomare E, Capria A, Bartolozzi C.

Eur J Radiol. 2012 Jun;81(6):1173-8.

 

22. Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.

Sacco R, Faggioni L, Bargellini I, Romano A, Bertini M, Ginanni B, Battaglia V, Bertoni M, Bozzi E, Federici G, Metrangolo S, Parisi G, Neri E, Sodini E, Tumino E, Bresci G, Bartolozzi C.

J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S234-8

 

23. Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?

Sacco R, Bargellini I, Ginanni B, Bertini M, Faggioni L, Federici G, Romano A, Bertoni M, Metrangolo S, Altomare E, Parisi G, Tumino E, Scaramuzzino A, Bresci G, Bartolozzi C.

Expert Rev Anticancer Ther. 2012 Jul;12(7):869-75

 

24. Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study.

Sacco R, Faggioni L, Bargellini I, Ginanni B, Battaglia V, Romano A, Bertini M, Bresci G, Bartolozzi C.

Dig Liver Dis. 2013 Sep;45(9):776-81.

 

25. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.

Sacco R, Romano A, Mazzoni A, Bertini M, Federici G, Metrangolo S, Parisi G, Nencini C, Giampietro C, Bertoni M, Tumino E, Scatena F, Bresci G.

J Crohns Colitis. 2013 Dec;7(12):e692-7.

 

26. GRANULOCYTAPHERESIS IN STEROID-DEPENDENT AND STEROID-RESISTANT PATIENTS WITH INFLAMMARORY BOWEL DISEASE: A PROSPECTIVE OBSERVATIONAL STUDY

R. Sacco, A. Romano, M. Bertini, G. federici, S. Metrangolo, G. Parisi, C. Nencini,
C. Giampietro, M. Bertoni, A. Mazzoni, E. Tumino, F. Scatena, A. Scaramuzzino, G. Bresci

Digestive and Liver Disease 45S (2013), S55-S218

 

27. PROPOSAL OF A MODIFIED PHENOTYPE-BASED RADIOLOGICAL CLASSIFICATION: THE MAGNETIC RESONANCE CROHN’S DISEASE SEVERITY INDEX (MR-CSI)

R. Sacco, E. Neri, L. Faggioni, R. Scandiffo, D. Lauretti, A. Romano, M. Bertini, M. Bertoni, g. Federici, S. Metrangolo, G. Parisi, A. Scaramuzzino, E. Tumino, G. Bresci, C. Bartolozzi

Digestive and Liver Disease 45S (2013), S55-S218

 

28. Liver perfusion CT for non-invasive assessment of response to sorafenib

therapy in patients with advanced HCC: preliminary findings

R. Sacco, L. Faggioni, I. Bargellini, B. Ginanni, A. Romano, M. Bertini, E. Neri, V. Mismas, A. Ricchiuti, O. Perrone, G. Federici, G. Parisi, E. Tumino, S. Metrangolo, G. Bresci, C. Bartolozzi

Digestive and Liver Disease 45S (2013), S1-S48

 

29. RESIDUAL VIABLE TUMOR VOLUME MEASUREMENT FOR EARLY PROGNOSTIC ASSESSMENT OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB

R. Sacco, I. Bargellini, A. Scionti, G. Masi, C. Caparello, B. Ginanni, C. Vivaldi, A. Romano, G. Bresci, A. Falcone, C. Bartolozzi

United European Gastroenterology Journal 1 (1S)

 

30. CONCOMITANT VERSUS SEQUENTIAL TREATMENT WITH TACE AND

SORAFENIB IN HCC PATIENTS

R. Sacco, A. Romano, I. Bargellini, B. Ginanni, V. Mismas, C. Vivaldi, C Caparello,, G. Musettini, L. Fornaro, G. Masi, L. Faggioni, G. Bresci, for the ITA.LI.CA. Group

Digestive and Liver Disease 46 (2014) e 18-e42

 

31. EFFICACY OF SORAFENIB ACCORDING TO THE NUMBER OF PRIOR TACE

PROCEDURES IN HEPATOCELLULAR CARCINOMA PATIENTS

R. Sacco, A. Romano, M. Bertini, S. Metrangolo, G. Parisi, M. Bertoni, G. Federici, A. Scaramuzzino, V. Mismas, B. Ginanni, I. Bargellini. L. Fornaro, G. Masi, G. Bresci, ITA.LI.CA Group

Journal of Hepatology 2014 vol 60 S361-S522

 

32. CONCOMITANT VERSUS SEQUENTIAL TREATMENT WITH TACE AND SORAFENIB IN HCC PATIENTS

R. Sacco, A. Romano, I. Bargellini, B. Ginanni, V. Mismas, C. Vivaldi, C Caparello,, G. Musettini, G. Masi, L. Faggioni, G. Bresci, for the ITA.LI.CA. Group

Journal of Hepatology 2014 vol 60 S361-S522

 

33. CORRELATION BETWEEN LDH LEVELS AND RESPONSE TO SORAFENIB IN HCC PATIENTS

Rodolfo Sacco, Lorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, Gianna Musettini, Gianluca Masi, valeria Mismas, Barbara Ginanni, Antonio Romano, Giampaolo Bresci and ITA.LI.CA Group

EASL – HCC SUMMIT GENEVA SWIZERLAND FEBRUARY 13-16, 2014

 

34. LONG TERM EFFICACY OF GRANULOCYTE-MONOCYTE-APHERESIS IN ULCERATIVE COLITIS ELDERLY PATIENTS. THE ITALIAN REGISTRY OF TERAPEUTIC APHERESIS

R.Sacco, V.D’Ovidio,, A. Romano, M.Bertini, M.Bertoni, G.Federici, S. Metrangolo, G.Parisi, E. Tumino,V.Mismas,G. Bresci, P.Vernia

Digestive and Liver Disease 47S (2015) e69-e208

 

35. ADHERENCE TO EASL-EORTC CLINICAL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA IN FIELD PRACTICE: RESULTS FROM THE ITALICA DATABASE

R. Sacco, A. Romano, V Mismas, S. Marceglia, M. Bertini, L. Giacomelli, M. Bertoni, G. Federici, S. Metrangolo. G. Parisi, E. Tumino, G. Bresci

Digestive and Liver Disease 47S (2015) e69-e208

 

36. EFFICACY OF SORAFENIB IN PATIENTS WITH INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA RESULTS FROM THE ITALICA DATABASE

R.Sacco, A.Romano, V.Mismas, M.Bertini, M: Bertoni, G. Federici, S. Metrangolo, G. Parisi, E. Tumino, G. Bresci

Digestive and Liver Disease 47S (2015) e69-e208

 

37. ASSESMENT OF CLINICAL AND RADIOLOGICAL RESPONSE TO SORAFENIB IN

HEPATOCELLULAR CARCINOMA PATIENTS

Rodolfo Sacco, Valeria Mismas, Antonio Romano, Marco Bertini, Michele Bertoni, Graziana Federici, Salvatore Metrangolo, Giuseppe Parisi, Emanuele Tumino, Giampaolo Bresci, Luca Giacomelli, Sara Marceglia, Irene Bargellini

World J Hepatology 2015 January 27; 7(1). 33-39

 

38. Transarterial radioembolization for hepatocellular carcinoma: An update and perspective

Rodolfo sacco, Valeria Mismas, Sara Marceglia, Antonio Romano, Luca Giacomelli, Marco Bertini, Graziana Federici, Salvatore Metrangolo, Giuseppe Parisi, Emanuele Tumino, Giampaolo Bresci, Ambra Corti, Manuel Tredici, Michele Piccinno, Luigi Giorgi, Carlo Bartolozzi, Irene Bargellini

World J Hepatology 2015 June 7; 21(21): 6518-6525

 

39. ADHERENCE TO EASL-EORTC CLINICAL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA IN FIELD PRACTICE: RESULTS FROM THE ITA.LI.CA DATABASE

R. Sacco, Valeria Mismas, Luca Giacomelli, Sara Marceglia, Antonio Romano, Marco Bertini, Michele Bertoni, Graziana Federici, Salvatore Metrangolo, Giuseppe Parisi, Emanuele Tumino, Giampaolo Bresci

ILCA ANNUAL CONFERENCE 4-6 September 2015

 

40. Curative therapies for hepatocellular carcinoma: an update and perspectives

Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Ranieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino & Giuseppe Cabibbo

Expert Review of Anticancer Therapy 2016 Feb; 16 (2): 169-75